MediView, LLC is a medical device company based in Cleveland, Ohio, founded in 2017. It specializes in augmented reality surgical navigation systems aimed at enhancing the surgical process for healthcare providers. The company's flagship product utilizes extended reality technology to improve the accuracy and efficacy of cancer therapies, specifically in the ablation and biopsy of cancerous tumors. MediView's innovative approach includes real-time, fused-holographic visualization, allowing surgeons to navigate procedures with 3D augmented reality. This technology supports telehealth initiatives and enables remote collaboration, allowing for a more effective examination of patients compared to traditional 2D displays.
Lucem Health develops a remote diagnostics platform designed to connect remote patient telemetry and biosensing devices with AI algorithms. Lucem's platform focuses on data ingest, orchestration, and connectivity, enabling clinicians to provide more effective continuous care and empower consumers to have better control of their health and well-being.
Karkinos Healthcare is a technology-driven platform that focuses on oncology, aiming to provide accessible cancer care and early diagnosis of common cancers. The company develops comprehensive healthcare solutions that bring cancer services closer to patients, ensuring that access and affordability do not hinder individuals from receiving necessary care. By emphasizing early detection and diagnosis, Karkinos Healthcare strives to improve patient outcomes and make cancer care more inclusive for everyone.
Medically Home Group, Inc., based in Boston, Massachusetts, offers a virtual hospital program designed to deliver in-home medical care services. Founded in 2016, the company focuses on providing patient-centered care for individuals with serious or complex illnesses, including conditions such as heart failure, pneumonia, urinary tract infections, cellulitis, and respiratory issues. Medically Home's innovative model enables the safe transition of medical care from traditional hospital settings to patients' homes, allowing for centralized, on-demand management of acute medical needs. This approach connects patients with caregivers while facilitating monitoring and communication, ensuring that patients and their families receive comprehensive support in a familiar environment.
Tympany Medical focuses on advancing minimally invasive ear surgeries through innovative technology. The company has developed a specialized ear surgery device that provides a sterile endoscopic solution for complex procedures in otolaryngology. This device addresses key challenges related to the usability and flexibility of traditional endoscopes, allowing surgeons to benefit from enhanced visualization while preserving their two-handed operating techniques. By reducing the necessity for mastoidectomies, Tympany Medical aims to improve surgical outcomes and streamline the process of ear surgeries, ultimately enhancing patient care in the field of ENT.
JOGO Health specializes in digital therapeutics aimed at treating neuromuscular conditions and chronic pain. The company utilizes a combination of wearable sensors and a patented mobile application that employs artificial intelligence, machine learning, and virtual reality to deliver tailored treatment protocols and interactive games. These solutions focus on muscle relaxation, movement coordination, and neuromuscular re-education, all rooted in the principles of neuroplasticity. JOGO therapy is administered through a service model that can occur in medical offices, during home visits, or via telemedicine, facilitated by certified therapists. The company's approach received FDA 510(k) exemption in March 2020, and its services are reimbursed by Medicare and commercial payers for neuro-muscular re-education, thereby enhancing patient adherence to rehabilitation and improving overall health outcomes.
Senda Biosciences is pioneering the field of Intersystems Biology to create novel treatments for human disease. Intersystems Biology focuses on how molecular connections between botanical, bacterial, and human cells—coevolved over millennia—define health and disease. Senda's Intersytems Biology discovery platform, built using new techniques in machine learning and computational biology, has been able to generate novel, actionable insights into the trillions of interspecies molecular connections in the human body, and harnesses the power of this "pharmacy within us" with novel pharmacological approaches. The power of the Senda platform is illustrated by six preclinical programs in oncology, neurology, chronic disease, and metabolic disease.
Medically Home Group, Inc., based in Boston, Massachusetts, offers a virtual hospital program designed to deliver in-home medical care services. Founded in 2016, the company focuses on providing patient-centered care for individuals with serious or complex illnesses, including conditions such as heart failure, pneumonia, urinary tract infections, cellulitis, and respiratory issues. Medically Home's innovative model enables the safe transition of medical care from traditional hospital settings to patients' homes, allowing for centralized, on-demand management of acute medical needs. This approach connects patients with caregivers while facilitating monitoring and communication, ensuring that patients and their families receive comprehensive support in a familiar environment.
Adaptive Phage Therapeutics, Inc. specializes in developing therapeutic solutions to combat the increasing threat of multi-drug resistant (MDR) bacteria. Founded in 2016 and based in Gaithersburg, Maryland, the company utilizes a unique resource known as PhageBank, which is an extensive and dynamic collection of bacteriophages—viruses that specifically target and attack harmful bacteria. Through a rapid system that matches these phages to individual patient bacterial infections, Adaptive Phage Therapeutics aims to enhance treatment options for patients suffering from MDR infections. Their innovative approach enables medical researchers to create tailored therapies that effectively detect and eliminate resistant bacterial strains.
Diagnostic Robotic develops a signal-agnostic artificial intelligence system for healthcare insurers, providers, and patients. It allows to build powerful predictive analytics models that will solve a world-wide challenge, strained health budgets, and workforces.
Diagnostic Robotic was founded on 2017 and is headquartered in Tel Aviv, Israel.
Adaptive Phage Therapeutics, Inc. specializes in developing therapeutic solutions to combat the increasing threat of multi-drug resistant (MDR) bacteria. Founded in 2016 and based in Gaithersburg, Maryland, the company utilizes a unique resource known as PhageBank, which is an extensive and dynamic collection of bacteriophages—viruses that specifically target and attack harmful bacteria. Through a rapid system that matches these phages to individual patient bacterial infections, Adaptive Phage Therapeutics aims to enhance treatment options for patients suffering from MDR infections. Their innovative approach enables medical researchers to create tailored therapies that effectively detect and eliminate resistant bacterial strains.
Securisyn Medical, LLC is a medical technology company specializing in the manufacture and supply of oxygen delivery systems for patients on mechanical ventilation. Founded in 2011 and based in Highlands Ranch, Colorado, the company aims to enhance the safety of ventilated patients by preventing unplanned extubation and its related complications. Securisyn Medical's solutions are designed to provide reassurance to patients, their families, and healthcare practitioners while also reducing healthcare costs through ethical and sustainable practices. The company serves medical providers and facilities across the United States, focusing on collaborative efforts to eliminate preventable deaths associated with airway management in emergency and intensive care settings.
NewCompliance Group B.V. develops and delivers dashboards that provide insights and improves the safety and efficiency in hospitals during the entire surgical process. It offers Operating Room Cockpit system that integrates and draws data from EMR, building, and other operating room (OR) equipment. The company’s OR Cockpit tracks, validates, and interprets data and display essential information needed by clinical staff during procedures. It also provides OR Financial that OR managers and hospital executives detailed and complete insight into the cost of individual surgeries by bringing together existing data; and OR Analytics platform that draws data from the EMR, facilities, and other major OR equipment to allow the user to design any type of combined and visual analysis in real-time. The company serves customers in Europe and the United States. The company was founded in 2006 and is based in The Hague, the Netherlands with additional offices in Nijmegen, the Netherlands; San Rafael, California; and Houston, Texas.
FundamentalVR have been working with leading pharmaceutical companies to combine virtual and mixed reality with haptic feedback using their ‘FeelRealVR’ platform to create simulated surgical procedures to help educate and train healthcare professionals.
AtriAN Medical, based in Galway, Ireland, is a medical device company that focuses on treating atrial fibrillation through innovative technology developed at the Mayo Clinic. The company utilizes a technique called micro Pulsed Electric Fields (mPEF) to selectively ablate hyperactive tissues while preserving the surrounding myocardium. By employing a catheter to deliver short pulses of electrical energy, AtriAN's device targets the origin of the condition externally, minimizing damage to the heart muscle. This approach allows physicians to provide effective treatment options for patients suffering from atrial fibrillation without the risks associated with traditional methods.
Eko harnesses the power of smartphones and cloud data for monitoring patients with cardiovascular diseases. It has built a platform of non-invasive cardiovascular monitoring devices, clinical software, and point-of-care decision support algorithms to improve the delivery of cardiovascular care. In 2015, Eko launched the Eko Core Digital Stethoscope, the first FDA-cleared digital stethoscope on the market to wirelessly stream heart and lung sound to HIPAA-compliant software. For the first time in history, patient sounds can be integrated with electronic health records (EHRs) for more seamless referrals, documentation, and monitoring. Eko was established in 2013 and is based in Berkeley, California.
Safely Health operates an online platform designed to promote safe sexual practices by enabling users to import their test results and verify their STD and COVID-19 status. Founded in 2015 and based in Los Angeles, the company aims to create a trusted, private, and secure environment for individuals seeking to share their health information with potential partners. Safely Health is not just an app but a comprehensive healthcare initiative that collaborates with leading healthcare organizations, including Quest and Labcorp, as well as public health entities like the CDC. By partnering with nonprofit organizations, influencers, and social media platforms, Safely Health seeks to empower users to take control of their sexual health and reduce the spread of STDs, ultimately fostering a safer and more enjoyable dating experience.
GYANT.com, Inc. specializes in developing an artificial intelligence-based chatbot application designed to enhance communication between physicians and patients. The GYANT platform allows physicians to assist patients in receiving diagnoses, prescriptions, and treatment recommendations through an initial diagnostic process that involves a series of questions. The company serves a range of healthcare providers, including hospitals and integrated delivery networks, by offering a digital front door solution that streamlines patient navigation to appropriate care settings and in-network resources. By utilizing natural language processing, GYANT's technology aims to improve patient engagement, facilitate healthcare access, and promote process automation, ultimately reducing costs and time for both patients and healthcare providers. Founded in 2016, GYANT is headquartered in Corte Madera, California.
GIBLIB is a California-based company and is the "Netflix" of Medical Education. It is a place for surgeons to share medical lectures and surgical videos. Founded in 2015, GIBLIB is headquartered in Los Angeles, California.
Marigold Health operates a social network community platform designed to provide text-based group therapies for individuals facing mental health and substance use challenges. The platform facilitates anonymous chat support groups, allowing patients to connect with peers and receive assistance from coaches who have personal recovery experience. This approach not only fosters a stigma-free environment for recovery but also enhances patient engagement in community-based treatment. By partnering with treatment providers and managed care organizations within the Medicaid market, Marigold Health effectively augments traditional care models, enabling care teams to increase their capacity while delivering personalized support to patients.
Ambient Clinical Analytics is the creator of a software platform designed for data assimilation, communication and analytics. It is based on decision support tools initially deployed in the intensive care unit (ICU) or emergency department of hospitals. Our software consists of algorithms that mine data from electronic medical records (EMR). It then presents that data to the physicians and nurses so they may facilitate real-time clinical decision making and care delivery. These products are positioned as add on applications that are designed to easily integrate with the current major EMR providers.
Geneticure Inc. is a pharmacogenetic testing company focused on developing personalized medicine solutions for patients with hypertension. Founded in 2012 and based in Eden Prairie, Minnesota, the company offers a non-invasive genetic test that analyzes DNA from a cheek swab to identify genetic variants related to the renal, vascular, and cardiac systems. This information helps clinicians determine the most effective treatment options tailored to individual patients based on their unique genetic profiles. Geneticure's testing process includes DNA extraction, genotyping, and the provision of genetic results directly to healthcare providers, accompanied by a decision tree that prioritizes functional genes. This personalized approach aims to optimize blood pressure therapy and improve patient outcomes. Additionally, Geneticure is working on two more pharmacogenomic panels to expand its offerings in personalized medicine.
Eko harnesses the power of smartphones and cloud data for monitoring patients with cardiovascular diseases. It has built a platform of non-invasive cardiovascular monitoring devices, clinical software, and point-of-care decision support algorithms to improve the delivery of cardiovascular care. In 2015, Eko launched the Eko Core Digital Stethoscope, the first FDA-cleared digital stethoscope on the market to wirelessly stream heart and lung sound to HIPAA-compliant software. For the first time in history, patient sounds can be integrated with electronic health records (EHRs) for more seamless referrals, documentation, and monitoring. Eko was established in 2013 and is based in Berkeley, California.
Helixis
Venture Round in 2018
Helixis, Inc. is a company that develops low-cost molecular diagnostic products.
DayTwo Ltd. is a precision medicine company based in Tel Aviv-Yafo, Israel, that focuses on using gut microbiome analysis to provide personalized health solutions for metabolic diseases such as diabetes, prediabetes, and obesity. Founded in 2015, the company utilizes gut microbiome sequencing to create tailored Food Prescriptions™ that help individuals manage their blood sugar levels, improve energy, and achieve weight loss. Their digital platform offers actionable dietary recommendations based on individual biometrics and lifestyle factors, ensuring that patients receive insights that are practical and easy to follow. DayTwo also employs a telehealth service, where Certified Diabetes Care and Education Specialists and Registered Dietitians support patients through a smartphone application, allowing for progress tracking and communication. The effectiveness of DayTwo's approach is measured using clinical outcomes such as A1C levels and Time In Range, with the potential for full fee reimbursement for those who adhere to the protocol.
AliveCor, Inc. is a technology company that develops digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile devices. Its flagship product, KardiaMobile, provides instant detection of common heart arrhythmias and allows users to track blood pressure and weight, as well as store recorded EKGs. The company also offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed readings with their healthcare providers. Additionally, AliveCor has introduced KardiaCare, a digital health subscription service that facilitates the management of heart health at home. Founded in 2010 and headquartered in Mountain View, California, AliveCor is recognized for its pioneering efforts in using machine learning techniques to enhance cardiac care and improve early detection of conditions such as atrial fibrillation.
Torax Medical, Inc. develops and markets products/devices to restore the barrier function of sphincters. The company’s products include LINX, a reflux management system to treat patients diagnosed with gastroesophageal reflux disease; and FENIX, a continence restoration system for the treatment of fecal incontinence. It sells its products in Europe and the United States. Torax Medical, Inc. was founded in 2002 and is based in Shoreview, Minnesota. As of March 23, 2017, Torax Medical, Inc. operates as a subsidiary of Ethicon, Inc.
Cardero Therapeutics is a start-up pharmaceutical company that is developing a novel class of therapeutics that induces the formation of new mitochondria (mitochondrial biogenesis) and enhances mitochondrial function in response to metabolic demand. Chronic depletion of mitochondria, the principal source of cellular ATP, has been directly linked to the progression of heart failure, sarcopenia, and neurodegeneration. Cardero Therapeutics is collaborating with numerous academic medical centers to advance novel drug candidates structurally based on a newly discovered human hormone that appears to fundamentally regulate mitochondrial density and function in all tissues. Cardero Therapeutics believes that enhancing myocyte bioenergetics will comprise an innovative therapeutic approach complementary to currently available cardiovascular drugs. The company’s clinical development focus is the lethal cardiomyopathy associated with orphan diseases characterized by loss of mitochondria in muscle and heart, resulting in heart failure that is poorly responsive to current medical interventions. Initial clinical trials are directed toward Duchenne muscular dystrophy and Friedreich’s ataxia.
Lifecode, Inc. is a molecular diagnostics company specializing in next-generation sequencing (NGS) technology, particularly in the field of oncology. Based in Foster City, California, the company develops a range of NGS-based cancer assays, including its flagship product, the Lifecode Pan Cancer Somatic Panel, designed for use in metastatic and rare cancers, as well as for patients who have exhausted standard treatment options or are exploring clinical trials. Lifecode aims to facilitate informed treatment decisions by providing clinical information to healthcare providers. To address the complexities of genomic data interpretation, Lifecode has assembled a skilled team with expertise in various scientific disciplines, including data science and molecular biology. The company is supported by funding from prominent investors, and it operates with a dual focus on software development and clinical laboratory services. Lifecode’s innovative approach is positioned to enhance personalized cancer care through accessible and interpretable genomic insights.
Assurex Health is a personalized medicine company dedicated to helping clinicians determine the right medication for individual patients with medical conditions. Assurex Health’s proprietary Genesight® technology is based on pharmacogenomics – the study of the genetic factors that influence an individual’s response to drug treatments – as well as evidence-based medicine and clinical pharmacology.
Ambra Health is a medical data and image management software-as-a-service company that provides a cloud-based platform for healthcare providers. The platform is designed to enhance imaging innovation and improve collaborative care workflows by offering secure and easy access to medical images. It serves a diverse clientele, including major health systems and radiology practices, enabling them to streamline their operations and enhance patient care. Ambra Health's solutions focus on agility, interoperability, and user-friendly design, allowing organizations to adopt and integrate the technology effectively while improving business outcomes. The company aims to meet the evolving needs of the healthcare industry by delivering innovative medical image management solutions.
Seres Health, now known as Seres Therapeutics, Inc., is a clinical-stage therapeutics company focused on the development of microbiome-based drugs aimed at treating various diseases associated with dysbiosis. The company specializes in Ecobiotic therapeutics designed to restore health by repairing the microbiome's function. Its lead product candidate, SER-109, is currently in Phase III clinical trials to prevent the recurrence of Clostridium difficile infection (CDI). Additionally, Seres is advancing several other candidates, including SER-287, which is in a Phase IIb study for ulcerative colitis, and SER-401, currently in Phase Ib trials for use in combination with checkpoint inhibitors in metastatic melanoma patients. Other candidates under development include SER-262 for initial CDI recurrence and SER-155 for modulating the microbiome in patients post-stem cell transplants. The company collaborates with organizations like Nestec Ltd. and Memorial Sloan Kettering Cancer Center, and was founded in 2010 in Cambridge, Massachusetts.
Better is a personal health assistant service founded in 2013 and based in Palo Alto, California. The company offers free access to symptom advice and a comprehensive health database, assisting users in collecting their health records from various medical providers. Better also provides round-the-clock support from healthcare professionals who help navigate insurance claims and schedule appointments. Developed in collaboration with Mayo Clinic and Social+Capital Partnership, the service combines free tools with premium access to a dedicated team of personal health assistants, enabling users to focus more on their health and less on the logistical aspects of healthcare management.
Ambient Clinical Analytics is the creator of a software platform designed for data assimilation, communication and analytics. It is based on decision support tools initially deployed in the intensive care unit (ICU) or emergency department of hospitals. Our software consists of algorithms that mine data from electronic medical records (EMR). It then presents that data to the physicians and nurses so they may facilitate real-time clinical decision making and care delivery. These products are positioned as add on applications that are designed to easily integrate with the current major EMR providers.
Bluesight is a software tool developed by Kit Check, Inc. that focuses on substance tracking and drug diversion detection within hospital pharmacies. This platform is part of a broader suite of cloud-based solutions designed to enhance the efficiency of pharmacy operations, including medication tracking and kit automation. Kit Check, Inc. utilizes Internet of Things (IoT) technology to significantly reduce kit replenishment time while increasing accuracy and minimizing errors. The company serves hospitals and pharmacies throughout the United States and Canada, tracking a substantial volume of medication, which contributes to improved supply chain management and operational safety. Founded in 2011 and based in Washington, D.C., Kit Check continues to innovate in the healthcare technology sector.
Torax Medical, Inc. develops and markets products/devices to restore the barrier function of sphincters. The company’s products include LINX, a reflux management system to treat patients diagnosed with gastroesophageal reflux disease; and FENIX, a continence restoration system for the treatment of fecal incontinence. It sells its products in Europe and the United States. Torax Medical, Inc. was founded in 2002 and is based in Shoreview, Minnesota. As of March 23, 2017, Torax Medical, Inc. operates as a subsidiary of Ethicon, Inc.
The Kang San Global Medical Technology (Beijing) Co., Ltd. is a hi-tech enterprise of one for the country at all levels of the hospital to provide advanced specialist inspection services, and the establishment of the National Laboratory of Kang Sheng Global Medical Special Inspection Center. Of the center's national service network belongs wholly owned ...
Torax Medical, Inc. develops and markets products/devices to restore the barrier function of sphincters. The company’s products include LINX, a reflux management system to treat patients diagnosed with gastroesophageal reflux disease; and FENIX, a continence restoration system for the treatment of fecal incontinence. It sells its products in Europe and the United States. Torax Medical, Inc. was founded in 2002 and is based in Shoreview, Minnesota. As of March 23, 2017, Torax Medical, Inc. operates as a subsidiary of Ethicon, Inc.
Kardia Health Systems is a healthcare information technology firm offering the delivery of specialty medicine, starting with cardiology. Using Internet technology and a Software-as-a-Service (SaaS) business model, Kardia makes this technology accessible to practices of varying sizes. Kardia Health Systems, Inc. was incorporated in 2006 and is based in Golden Valley, Minnesota.
Kardia Health Systems is a healthcare information technology firm offering the delivery of specialty medicine, starting with cardiology. Using Internet technology and a Software-as-a-Service (SaaS) business model, Kardia makes this technology accessible to practices of varying sizes. Kardia Health Systems, Inc. was incorporated in 2006 and is based in Golden Valley, Minnesota.
Naviscan, Inc. is the leader in organ-specific molecular imaging. The company designs, manufactures, and distributes a high-resolution PET scanner which provides unprecedented visualization of small body parts. While Naviscan’s PET scanner can image virtually any body part that can fit into the gantry, it is most often utilized as an adjunct to conventional imaging technologies by clinicians who stage and manage breast cancer. Surgeons, radiologists, nuclear physicians, and oncologists in hospitals and breast clinics use our compact, mobile and easy-to-use PET scanner to precisely characterize breast cancer, enhance surgical planning, monitor patient response to therapy, and evaluate suspected recurrence.
NBI Development is an implantable medical device company focused on the development of novel neuromodulation therapies. The company develops Neuromodulation, the use of electrical impulses to manage activity in the nervous system.
Naviscan, Inc. is the leader in organ-specific molecular imaging. The company designs, manufactures, and distributes a high-resolution PET scanner which provides unprecedented visualization of small body parts. While Naviscan’s PET scanner can image virtually any body part that can fit into the gantry, it is most often utilized as an adjunct to conventional imaging technologies by clinicians who stage and manage breast cancer. Surgeons, radiologists, nuclear physicians, and oncologists in hospitals and breast clinics use our compact, mobile and easy-to-use PET scanner to precisely characterize breast cancer, enhance surgical planning, monitor patient response to therapy, and evaluate suspected recurrence.
Torax Medical, Inc. develops and markets products/devices to restore the barrier function of sphincters. The company’s products include LINX, a reflux management system to treat patients diagnosed with gastroesophageal reflux disease; and FENIX, a continence restoration system for the treatment of fecal incontinence. It sells its products in Europe and the United States. Torax Medical, Inc. was founded in 2002 and is based in Shoreview, Minnesota. As of March 23, 2017, Torax Medical, Inc. operates as a subsidiary of Ethicon, Inc.